eLifeNeurosciencePeer-reviewed journal article
Microtubule assembly by soluble tau impairs vesicle endocytosis and excitatory neurotransmission via dynamin sequestration in Alzheimer's disease synapse model
Tetsuya HoriiD, Kohgaku EguchiiD, Han-Ying WangiD, Tomohiro MiyasakaiD, Laurent GuillaudiD, Zacharie TaoufiqiD, Satyajit MahapatraiD, Hiroshi Yamada, Kohji TakeiiD, Tomoyuki TakahashiiD
Abstract
Elevation of soluble wild-type (WT) tau occurs in synaptic compartments in Alzheimers disease. We addressed whether tau elevation affects synaptic transmission at the calyx of Held in brainstem slices. Whole-cell loading of WT human tau (h-tau) in presynaptic terminals at 10-20 {micro}M caused microtubule (MT) assembly and activity-dependent rundown of excitatory neurotransmission. Capacitance measurements revealed that the primary target of WT h-tau is vesicle endocytosis. Blocking MT assembly using nocodazole prevented tau-induced impairments of endocytosis and neurotransmission. Immunofluorescence imaging analyses revealed that MT assembly by WT h-tau loading was associated with an increased bound fraction of the endocytic protein dynamin. A synthetic dodecapeptide corresponding to dynamin-1-pleckstrin-homology domain inhibited MT-dynamin interaction and rescued tau-induced impairments of endocytosis and neurotransmission. We conclude that elevation of presynaptic WT tau induces de novo assembly of MTs, thereby sequestering free dynamins. As a result, endocytosis and subsequent vesicle replenishment are impaired, causing activity-dependent rundown of neurotransmission. Significance StatementWild-type human recombinant tau loaded in rodent presynaptic terminals inhibited vesicle endocytosis, thereby causing activity-dependent rundown of excitatory transmission. This endocytic block is caused by a sequestration of dynamin by excess microtubules newly assembled by tau and can be rescued by a peptide inhibiting the microtubules-dynamin interaction, or by the microtubule disassembler nocodazole. Thus, synaptic dysfunction can be induced by pathological increase of endogenous soluble tau in Alzheimer disease slice model.
- organism: rat
- assay: electronic health records
- research focus: cell-cell communication
- research focus: differential expression
- research focus: protein structure prediction
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 36
- FWCI
- 4.79
- Field percentile
- top 3%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tau accumulation activates STAT1 triggering memory deficits via suppressing NMDA receptor expression
Xiao-Guang Li, Xiao-Yue Hong, … Jian‐Zhi Wang·EMBO ReportsPeer-reviewed·May 13, 2019
- Impaired α-tubulin re-tyrosination leads to synaptic dysfunction and is a feature of Alzheimer's disease
Leticia Peris, Xiaoyi Qu, … Annie Andrieux·bioRxiv·May 17, 2021
- Synaptotoxic effects of extracellular tau are mediated by its microtubule-binding region
Tomáš Ondrejčák, Neng‐Wei Hu, … Igor V. Klyubin·Acta NeuropathologicaPeer-reviewed·Jun 2, 2025
- rTg(TauP301L)4510 mice exhibit increased VGLUT1 in hippocampal presynaptic glutamatergic vesicles and increased extracellular glutamate release
Erika Taipala, Jeremiah C. Pfitzer, … Michael W. Gramlich·Frontiers in Synaptic NeurosciencePeer-reviewed·Aug 3, 2022
- Extracellular monomeric and aggregated tau efficiently enter human neurons through overlapping but distinct pathways
Lewis Evans, Thomas Wassmer, … Frederick J. Livesey·Cell ReportsPeer-reviewed·Mar 1, 2018
- Pharmacological restoration of deficits in mitochondrial trafficking rescues aberrant axonal activity in tauopathy
Marie H. Sabec, Oliver R Adam, Michael C. Ashby·bioRxiv·May 2, 2025